Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

The NHS has started delivering its spring COVID-19 vaccine booster to vulnerable individuals across England, with over half a ...

SkyCell has partnered with Microsoft to launch SkyMind, an artificial intelligence (AI)-powered solution designed to enhance ...

The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the ...

Endlyz is supported by leading investors, including SV Health Investors’ Dementia Discovery Fund, Oxford Science Enterprises, ...

The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin combined with doxorubicin, ...

Elekta has announced a partnership with Azra AI to improve cancer registry workflows using AI-powered automation. Combining ...

The European Commission (EC) has approved ustekinumab for the treatment of moderately to severely active Crohn’s disease in ...

Aspire Pharma Ltd is a global life sciences business, based in the UK, devoted to delivering true value to patients, ...

The One Health philosophy is described by WHO as ‘an integrated, unifying approach that aims to sustainably balance and ...